In addition, on the basis of our bioinformatics analysis, RCN1 is correlated with poor survival in kidney clear cell carcinoma, thus suggesting that RCN1 may be a potential target for cancer therapy. This evidence concerns the gene RCN1 and clear cell renal carcinoma.